BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 30606519)

  • 1. Polydopamine doped reduced graphene oxide/mesoporous silica nanosheets for chemo-photothermal and enhanced photothermal therapy.
    Liu R; Zhang H; Zhang F; Wang X; Liu X; Zhang Y
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():138-145. PubMed ID: 30606519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy.
    Lei W; Sun C; Jiang T; Gao Y; Yang Y; Zhao Q; Wang S
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110103. PubMed ID: 31546357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydopamine-doped virus-like mesoporous silica coated reduced graphene oxide nanosheets for chemo-photothermal synergetic therapy.
    Liao J; Zhang H; Wang X
    J Biomater Appl; 2020 Jul; 35(1):28-38. PubMed ID: 32279577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
    Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
    Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydopamine-functionalized nanographene oxide: a versatile nanocarrier for chemotherapy and photothermal therapy.
    Zhang X; Nan X; Shi W; Sun Y; Su H; He Y; Liu X; Zhang Z; Ge D
    Nanotechnology; 2017 Jul; 28(29):295102. PubMed ID: 28656906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabricating polydopamine-coated MoSe
    Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
    Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous Silica Coated Polydopamine Functionalized Reduced Graphene Oxide for Synergistic Targeted Chemo-Photothermal Therapy.
    Shao L; Zhang R; Lu J; Zhao C; Deng X; Wu Y
    ACS Appl Mater Interfaces; 2017 Jan; 9(2):1226-1236. PubMed ID: 28004583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid conjugated polydopamine functionalized mesoporous silica nanoparticles for synergistic targeted chemo-photothermal therapy.
    Chen C; Tang W; Jiang D; Yang G; Wang X; Zhou L; Zhang W; Wang P
    Nanoscale; 2019 Jun; 11(22):11012-11024. PubMed ID: 31140527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
    Tran VA; Vo VG; Shim K; Lee SW; An SSA
    Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
    Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(allylamine hydrochloride)-functionalized reduced graphene oxide for synergistic chemo-photothermal therapy.
    Roy S; Sarkar A; Jaiswal A
    Nanomedicine (Lond); 2019 Feb; 14(3):255-274. PubMed ID: 30676277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold modified polydopamine coated mesoporous silica nano-structures for synergetic chemo-photothermal effect.
    Rahoui N; Jiang B; Hegazy M; Taloub N; Wang Y; Yu M; Huang YD
    Colloids Surf B Biointerfaces; 2018 Nov; 171():176-185. PubMed ID: 30031302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
    Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
    Small; 2017 Jan; 13(2):. PubMed ID: 27735129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
    Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
    Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
    Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR-targeted delivery of DOX-loaded Fe
    Mu X; Zhang F; Kong C; Zhang H; Zhang W; Ge R; Liu Y; Jiang J
    Int J Nanomedicine; 2017; 12():2899-2911. PubMed ID: 28435266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplified Photoacoustic Signal and Enhanced Photothermal Conversion of Polydopamine-Coated Gold Nanobipyramids for Phototheranostics and Synergistic Chemotherapy.
    Liu Y; Li Z; Yin Z; Zhang H; Gao Y; Huo G; Wu A; Zeng L
    ACS Appl Mater Interfaces; 2020 Apr; 12(13):14866-14875. PubMed ID: 32153178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric Prodrug Grafted Hollow Mesoporous Silica Nanoparticles Encapsulating Near-Infrared Absorbing Dye for Potent Combined Photothermal-Chemotherapy.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Zhao Y
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6869-79. PubMed ID: 26937591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
    Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
    Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cRGD-Conjugated Fe
    Fan X; Yuan Z; Shou C; Fan G; Wang H; Gao F; Rui Y; Xu K; Yin P
    Int J Nanomedicine; 2019; 14():9631-9645. PubMed ID: 31824156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.